Non-invasive vagus nerve stimulation improves clinical and molecular biomarkers of Parkinson’s disease in patients with freezing of gait

[1]  Eric H. Chang,et al.  Specific vagus nerve stimulation parameters alter serum cytokine levels in the absence of inflammation , 2020, Bioelectronic medicine.

[2]  L. Metman,et al.  A Novel DBS Paradigm for Axial Features in Parkinson's Disease: A Randomized Crossover Study , 2020, Movement disorders : official journal of the Movement Disorder Society.

[3]  S. Choudhury,et al.  Inflammasome and α-synuclein in Parkinson's disease: A cross-sectional study , 2019, Journal of Neuroimmunology.

[4]  S. Choudhury,et al.  Noninvasive vagus nerve stimulation improves gait and reduces freezing of gait in Parkinson's disease , 2019, Movement disorders : official journal of the Movement Disorder Society.

[5]  John-Paul Taylor,et al.  Noninvasive vagus nerve stimulation to target gait impairment in Parkinson's disease , 2019, Movement disorders : official journal of the Movement Disorder Society.

[6]  D. Kell,et al.  Parkinson’s disease: a systemic inflammatory disease accompanied by bacterial inflammagens , 2019, bioRxiv.

[7]  Nitin B. Bangera,et al.  Exploration of the Impact of Brief Noninvasive Vagal Nerve Stimulation on EEG and Event‐Related Potentials , 2018, Neuromodulation : journal of the International Neuromodulation Society.

[8]  Christopher G. Wilson,et al.  A review of vagus nerve stimulation as a therapeutic intervention , 2018, Journal of inflammation research.

[9]  K. Helke,et al.  Vagus nerve stimulation improves locomotion and neuronal populations in a model of Parkinson's disease , 2017, Brain Stimulation.

[10]  Eleni Frangos,et al.  Access to Vagal Projections via Cutaneous Electrical Stimulation of the Neck: fMRI Evidence in Healthy Humans , 2017, Brain Stimulation.

[11]  V. Sinniger,et al.  Anti‐inflammatory properties of the vagus nerve: potential therapeutic implications of vagus nerve stimulation , 2016, The Journal of physiology.

[12]  S. Sveinbjornsdottir.  The clinical symptoms of Parkinson's disease , 2016, Journal of neurochemistry.

[13]  S. Muramatsu,et al.  Freezing of Gait in Parkinson's Disease Is Associated with Reduced 6-[18F]Fluoro-l-m-tyrosine Uptake in the Locus Coeruleus , 2016, Parkinson's disease.

[14]  Hong Jiang,et al.  Low‐Level Vagus Nerve Stimulation Attenuates Myocardial Ischemic Reperfusion Injury by Antioxidative Stress and Antiapoptosis Reactions in Canines , 2016, Journal of cardiovascular electrophysiology.

[15]  S. Silberstein,et al.  Vagus Nerve and Vagus Nerve Stimulation, a Comprehensive Review: Part II , 2016, Headache.

[16]  E. Ben-Menachem,et al.  Surgically implanted and non‐invasive vagus nerve stimulation: a review of efficacy, safety and tolerability , 2015, European journal of neurology.

[17]  M. Riva,et al.  Brain-derived neurotrophic factor: a bridge between inflammation and neuroplasticity , 2014, Front. Cell. Neurosci..

[18]  B. Galna,et al.  Cognition and Gait Show a Selective Pattern of Association Dominated by Phenotype in Incident Parkinson’s Disease , 2014, Front. Aging Neurosci..

[19]  A. Mahajan,et al.  Electrophysiological effects of right and left vagal nerve stimulation on the ventricular myocardium. , 2014, American journal of physiology. Heart and circulatory physiology.

[20]  M. Oshinsky,et al.  Noninvasive vagus nerve stimulation as treatment for trigeminal allodynia , 2014, PAIN®.

[21]  T. Wang,et al.  Involvement of MAPK/NF-κB Signaling in the Activation of the Cholinergic Anti-Inflammatory Pathway in Experimental Colitis by Chronic Vagus Nerve Stimulation , 2013, PloS one.

[22]  Habib Benali,et al.  The coeruleus/subcoeruleus complex in rapid eye movement sleep behaviour disorders in Parkinson’s disease , 2013, Brain : a journal of neurology.

[23]  B. Galna,et al.  Cholinergic dysfunction contributes to gait disturbance in early Parkinson's disease. , 2012, Brain : a journal of neurology.

[24]  Kensuke Kawai,et al.  [Vagus nerve stimulation therapy for epilepsy]. , 2011, Brain and nerve = Shinkei kenkyu no shinpo.

[25]  Navzer D. Engineer,et al.  Reversing pathological neural activity using targeted plasticity , 2011, Nature.

[26]  K. Rijkers,et al.  Vagus Nerve Stimulation in Refractory Epilepsy: Effects on Pro- and Anti-Inflammatory Cytokines in Peripheral Blood , 2010, Neuroimmunomodulation.

[27]  A. Teixeira,et al.  Serum levels of brain-derived neurotrophic factor correlate with motor impairment in Parkinson’s disease , 2010, Journal of Neurology.

[28]  K. Tracey.  Reflex control of immunity , 2009, Nature Reviews Immunology.

[29]  B. Bloem,et al.  Postural instability in Parkinson’s disease: the adrenergic hypothesis and the locus coeruleus , 2009, Expert review of neurotherapeutics.

[30]  V. Tronnier,et al.  Right-sided vagus nerve stimulation in humans: An effective therapy? , 2008, Epilepsy Research.

[31]  Nir Giladi,et al.  The challenge of evaluating freezing of gait in patients with Parkinson's disease , 2008, British journal of neurosurgery.

[32]  F. Marrosu,et al.  Vagus nerve stimulation increases norepinephrine concentration and the gene expression of BDNF and bFGF in the rat brain , 2007, Brain Research.

[33]  J. Kornhuber,et al.  BOLD fMRI deactivation of limbic and temporal brain structures and mood enhancing effect by transcutaneous vagus nerve stimulation , 2007, Journal of Neural Transmission.

[34]  P. Mcgeer,et al.  Therapeutic approaches to inflammation in neurodegenerative disease , 2007, Current opinion in neurology.

[35]  T. Connor,et al.  The Effects of Vagus Nerve Stimulation on Pro- and Anti-Inflammatory Cytokines in Humans: A Preliminary Report , 2005, Neuroimmunomodulation.

[36]  J. Ellis.  Cholinesterase Inhibitors in the Treatment of Dementia , 2005, The Journal of the American Osteopathic Association.

[37]  A. Mauskop,et al.  Vagus Nerve Stimulation Relieves Chronic Refractory Migraine and Cluster Headaches , 2005, Cephalalgia : an international journal of headache.

[38]  Martin Sarter,et al.  Developmental origins of the age-related decline in cortical cholinergic function and associated cognitive abilities , 2004, Neurobiology of Aging.

[39]  M. Beelke,et al.  Chronic vagus nerve stimulation improves alertness and reduces rapid eye movement sleep in patients affected by refractory epilepsy. , 2003, Sleep.

[40]  M. Beal.  Mitochondria, Oxidative Damage, and Inflammation in Parkinson's Disease , 2003, Annals of the New York Academy of Sciences.

[41]  G. Morris,et al.  Effects of Vagal Nerve Stimulation on Cognition and Quality of Life in Epilepsy , 2001, Epilepsy & Behavior.

[42]  C. Plata-salamán,et al.  Inflammation and Alzheimer’s disease , 2000, Neurobiology of Aging.

[43]  P. Hobson,et al.  Accuracy of diagnosis in patients with presumed Parkinson's disease. , 1999, Age and ageing.

[44]  H. Przuntek,et al.  Short communication Interleukin‐6 levels in cerebrospinal fluid inversely correlate to severity of Parkinson's disease , 1998, Acta neurologica Scandinavica.

[45]  P. Riederer,et al.  Time course of nigrostriatal degeneration in parkinson's disease , 1976, Journal of Neural Transmission.

[46]  S. Choudhury,et al.  Analysis of gait in Parkinson’s disease reflecting the effect of l-DOPA , 2019, Annals of Movement Disorders.

[47]  Nir Giladi,et al.  Freezing of gait in patients with advanced Parkinson's disease , 2001, Journal of Neural Transmission.

[48]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .